Bullboard Post History

by scarlet1967

Order by:

T.TH	RE:They act like big pharma. That's a problem In my opinion lack of transparent factual and frequent updates to broader... January 19, 2023
T.TH	RE:RE:Article from Bloomberg of note qwerty22 wrote: Egrifta doesn't impact subcutaneous fat... January 17, 2023
T.TH	RE:RE:RE:RE:RE:Article from Bloomberg of note Among Authors Drs Stanley and Grinspoon!!scarlet1967 wrote: &... January 17, 2023
T.TH	RE:RE:RE:RE:Article from Bloomberg of note Published today, VAT was the main cause of concern for... January 17, 2023
T.TH	RE:RE:RE:Article from Bloomberg of note Wino115 wrote: Would make sense just to partner on rights for... January 17, 2023
T.TH	Not sure this was posted before hopefully THTX knows https://clinicaltrials.gov/ct2/show/NCT02217345 “GH... January 14, 2023
T.TH	RE:RE:TH1902 oncology program Designing the basket trials There are various designs for basket... January 12, 2023
T.TH	From unjustified optimism to unjustified pessimism “The mandate of this Scientific Advisory Committee is to optimize the... January 10, 2023
T.TH	RE:RE:RE:It seems like.. We could say the same for their NASH asset, despite the promising results... January 10, 2023
T.TH	RE:It seems like.. "Regimen" January 10, 2023
T.TH	It seems like.. That it’s not only THTX who believes two long acting drugs regime... January 10, 2023
T.TH	RE:RE:RE:RE:Presentation is a good sign https://www.linkedin.com/posts/theratechnologies-inc_jpmorgan-sanfrancisco... January 10, 2023
T.TH	Tesamorelin https://patents.google.com/patent/US20220378880A1/en ... January 9, 2023
T.TH	RE:RE:New presentation up - realistic review. Wino115 wrote: Sorry - here's image: [img]https:/... January 8, 2023
T.TH	RE:RE:RE:RE:RE:RE:RE:RE:RE:National Bank On Th “Cancer risk In theory, there is a risk that use of tesamorelin—because it... January 5, 2023
T.TH	RE:Stocktwits continues to lose followers This letter was a step in the right direction so hopefully we will see more... January 4, 2023
T.TH	RE:RE:RE:RE:RE:RE:Letter “new accretive product acquisitions or in-licensing of commercial assets” &... January 4, 2023
T.TH	RE:RE:Another biotech in Nash “While the biotech studied the drug in NASH “as a model disease” in context... January 3, 2023
T.TH	Liver fibrosis in PLWH with NAFLD This was published December 2022 by Dr. Grinspoon and... January 2, 2023
T.TH	RE:Canadian Disclosure Law I think you mentioned the PR had too much information and I do think you have... December 29, 2022

Become a member today, It's free!

Bullboard Post History

by scarlet1967

RE:They act like big pharma. That's a problem

RE:RE:Article from Bloomberg of note

RE:RE:RE:RE:RE:Article from Bloomberg of note

RE:RE:RE:RE:Article from Bloomberg of note

RE:RE:RE:Article from Bloomberg of note

Not sure this was posted before hopefully THTX knows

RE:RE:TH1902 oncology program

From unjustified optimism to unjustified pessimism

RE:RE:RE:It seems like..

RE:It seems like..

It seems like..

RE:RE:RE:RE:Presentation is a good sign

Tesamorelin

RE:RE:New presentation up - realistic review.

RE:RE:RE:RE:RE:RE:RE:RE:RE:National Bank On Th

RE:Stocktwits continues to lose followers

RE:RE:RE:RE:RE:RE:Letter

RE:RE:Another biotech in Nash

Liver fibrosis in PLWH with NAFLD

RE:Canadian Disclosure Law

Featured News Links

One Property, One Focus on Advancing this Gold Project in Ontario

Options Trading for Retiring: Key Strategies in Balancing Retirement Income

Featured Company

Nextleaf Solutions Ltd C.OILS

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard Post History

by scarlet1967

Featured News Links

Featured Company